Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Clinical trial NCT06315400 · UNKNOWN

Trial details

NCT number: NCT06315400
Sponsor: Valenta Pharm JSC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human Acute Respiratory Infection Common Cold

Start date: 2023-12-19
Primary completion: 2025-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.